Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D supplementation in PCOS and reproductive outcomes
ChiCTR2100047286Phase 4Recruiting
- Sponsor
- Second Hospital of Shandong University
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vitamin d in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Second Hospital of Shandong University. Primary endpoints: Serum androgen levels and Insulin release test. Started Jun 2021; status: recruiting.
02
Drugs
vitamin d
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2100047286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047286.